Schiller, J. H., von Pawel, J., Schütt, P., Ansari, R. H., Thomas, M., Saleh, M., . . . Socinski, M. A. (2010). Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer. Journal of thoracic oncology, 5(12), . https://doi.org/10.1097/JTO.0b013e3181f4a5c9
Chicago-Zitierstil (17. Ausg.)Schiller, Joan H., et al. "Pemetrexed with or Without Matuzumab as Second-line Treatment for Patients with Stage IIIB/IV Non-small Cell Lung Cancer." Journal of Thoracic Oncology 5, no. 12 (2010). https://doi.org/10.1097/JTO.0b013e3181f4a5c9.
MLA-Zitierstil (9. Ausg.)Schiller, Joan H., et al. "Pemetrexed with or Without Matuzumab as Second-line Treatment for Patients with Stage IIIB/IV Non-small Cell Lung Cancer." Journal of Thoracic Oncology, vol. 5, no. 12, 2010, https://doi.org/10.1097/JTO.0b013e3181f4a5c9.